SCHEMBL3891190

SCHEMBL3891190

CC1CC2(CCN1C(=O)O)C(N1CCC1)=NC(=O)N2c1cccc(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 0.36
USP2 O75604 8/20 0.36
CYP1A2 P05177 8/20 0.36
CYP2C9 P11712 4/20 0.36
CYP2C19 P33261 4/20 0.36
TSHR P16473 4/20 0.36
BACE1 P56817 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 5/20 0.34
HIF1A Q16665 3/20 0.34
CYP2D6 P10635 2/20 0.34
BACE2 Q9Y5Z0 1/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALOX12 P18054 1/20 0.34
MMP14 P50281 3/20 0.33
ADAMTS5 Q9UNA0 3/20 0.33
MMP2 P08253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3891195 1.00 CYP3A4 (0.36) CYP3A4USP2CYP1A2CYP2C9CYP2C19
SCHEMBL8209403 0.87 BACE1 (0.37) BACE1
SCHEMBL3494461 0.87 BACE1 (0.37) BACE1
SCHEMBL3494462 0.87 BACE1 (0.37) BACE1
SCHEMBL3479516 0.86 MAPK14 (0.39) CYP3A4USP2CYP1A2BACE1MEN1
SCHEMBL3893080 0.86 MAPK14 (0.39) CYP3A4USP2CYP1A2BACE1MEN1
SCHEMBL3479619 0.84 KCNJ6 (0.35) CYP3A4USP2CYP1A2BACE1MEN1
SCHEMBL4249026 0.84 KCNJ6 (0.35) CYP3A4USP2CYP1A2BACE1MEN1
SCHEMBL13461566 0.82 BACE1 (0.38) BACE1MAPK1
SCHEMBL5326122 0.81 ADORA3 (0.39) CYP2C19BACE1KMT2AALDH1A1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091328-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-08-26 EP disclosed
WO-2008054698-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-05-08 WO disclosed